Companies, across a variety of industries, are increasingly taking a multi-channel approach to core product and service delivery. While a…
Read More →
To honor the 34th anniversary of the Americans with Disabilities Act (ADA), on July 26, 2024, the U.S. Department of…
Read More →
On August 1, 2024, Roseland Community Hospital Association filed a notice of data breach with the U.S. Department of Health…
Read More →
On August 9, 2024, Monte Nido filed a notice of data breach with the Attorney General of California after discovering…
Read More →
On August 7, 2024, Internal Medicine Associates, LLC d/b/a Gastrointestinal Medicine Associates (“Gastrointestinal Medicine Associates” or “GMA”) filed a notice…
Read More →
Foley Hoag LLP publishes this quarterly Update primarily concerning developments in product liability and related law from federal and state…
Read More →
The European Union (EU) Artificial Intelligence Act (AI Act), Regulation (EU) 2024/1689 of the European Parliament and of the Council…
Read More →
The U.S. Food and Drug Administration (FDA or Agency) rejected the new drug application (NDA) for a drug marketing approval…
Read More →
A recent New York Times article reported that dozens of spine surgery patients at NewYork-Presbyterian/Weill Cornell Medical Center were treated with a product…
Read More →
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors…
Read More →